Ellura contains a specific extract of cranberry that supports urinary tract health. Between cranberry supplements, there can be great variation in the quality of the extract used. Ellura is equivalent to 70g of fresh cranberries, standardised to provide the recommended dose of 36mg bioactive proanthocyanidins (PACs) in each capsule. The amount of PACs is important for an effective cranberry supplement, as PACs have been shown to be the most active component in causing bacterial anti-adhesion activity against E.coli.1,2
There is no evidence for any concern when using Ellura in pregnancy and lactation. However, it is recommended to speak with your healthcare professional before starting Ellura if you are pregnant or breastfeeding.
Ellura may be given to children under the age of 12 years, but only under the guidance of a healthcare professional.
Ellura is very well tolerated and has no reported side effects. It is important to speak with your healthcare professional if you are concerned about possible side effects.
There are no known interactions between Ellura capsules and other medications, however caution is advised if you are taking anticoagulant medication. If you are concerned about possible interactions, it is important to discuss this with your healthcare professional.
From the available data there is no recommendation to stop Ellura before surgery. However, it is important to discuss this with your healthcare professional, including your anaesthetist and surgeon.
Yes, Ellura is gluten free.
No, Ellura does not contain lactose.
Ellura capsules contain a specific extract of cranberry juice powder. However, the gelatin capsules are derived from fish – if you have a known allergy to fish or fish products, it is important to speak with your healthcare professional before taking Ellura.
Ellura has no known adverse effects in these situations.
References: 1. Howell et al, Dosage effect on uropathogenic E.coli anti-adhesion activity in urine following consumption of cranberry powder standardised for PAC content, BMC Infectious Diseases 2010:94 2. Howell AB. Bioactive compounds in cranberries and their role in prevention of urinary tract infections. Mol.Nutr.Food Res. 2007, 51, 732-737 3. Botto & Neuzillet, Effectiveness of cranberry preparation in reducing asymptomatic bacteriuria in patients with an ileal enterocystoplasty, Scandinavian Journal of Urology and Nephrology 2010 4. Prior et al, Multilaboratory validation of a standard method for quantifying proanthocyanidins in cranberry powders, Journal of the Science of Food and Agriculture, 2010.
Some of this research received funding from Pharmatoka.
References for Ellura advertisements
*Based on independent testing of PAC validated by BL-DMAC, and anti-adhesion activity, in 10 of the leading commercially available
cranberry supplements (evaluated by Aztec value 11/03/2012).
1. Howell AB. Whole Product Anti-Adhesion Activity Report. Rutgers University. 2011. 2. Howell AB. Whole Product Anti-Adhesion Activity Report. Rutgers University. 2013. 3. Jepson RG, et al. The Cochrane Library Review. 2012, Issue 10. 4. Howell AB, et al. BMC Infectious Diseases. 2010;10:94. 5. Botto & Neuzillet. Scand J Urol Nephrol. 2010;44:165-8.